Dr. Michael Anthony Carrasquilla, MD

Dr. Carrasquilla practices at Good Samaritan Regional Medical Center in Corvallis, Oregon, part of MultiCare Health System.

Dr. Carrasquilla's NPI, 1245724764, was assigned on June 18, 2018. Dr. Carrasquilla graduated from Rush Medical College of Rush University in 2018. Dr. Carrasquilla holds District of Columbia license MD210012205.

Dr. Carrasquilla's primary practice is Good Samaritan Regional Medical Center, at 3600 NW Samaritan Drive, Corvallis, OR 97339 in Benton County. The practice phone is (541) 768-5111.

Dr. Carrasquilla's primary practice is Good Samaritan Regional Medical Center in Corvallis, Oregon, part of MultiCare Health System. Dr. Carrasquilla is also affiliated with Samaritan Albany General Hospital. The medical group on file is Good Samaritan Regional Medical Center. Dmand AI also links Dr. Carrasquilla to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carrasquilla practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Carrasquilla's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Carrasquilla's licenses on file in 2 states: District of Columbia and Illinois.

CMS data shows 1,621 Medicare services from Dr. Carrasquilla across 17 procedure codes in 2024, for 207 Medicare patients. Medicare paid $130,770 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 207 Medicare patients who saw Dr. Carrasquilla in 2024. The largest group is 75 to 84, with 96 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Carrasquilla's median patient age at 70, with 47% women.

In 2024, Dr. Carrasquilla wrote 46 Medicare Part D claims for 22 patients. 98% of them were for generic drugs. CMS names the drug for 28 of them, across 1 drug with 11 or more claims each, at $278 in total drug cost. In 2020, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Carrasquilla for performance year 2024, reported as part of a group. Dr. Carrasquilla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carrasquilla as offering telehealth.

Dmand AI links 14 papers to Dr. Carrasquilla, published from 2020 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Prostatic Neoplasms. Dr. Carrasquilla has published most often in Front Oncol. Dr. Carrasquilla's most frequent co-authors are Sean Collins, MD, Deepak Kumar, MD and Brian Collins.

CMS Open Payments shows 21 general payments to Dr. Carrasquilla from 12 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Bioprotect Medical, Inc. paid the most, $328.

Dr. Carrasquilla graduated from Rush Medical College of Rush University in 2018.